Boxer Capital, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2017$41,200,000
-12.0%
500,0000.0%9.38%
-15.8%
Q2 2017$46,815,000
-26.5%
500,000
-50.0%
11.13%
-20.0%
Q1 2017$63,670,000
+68.6%
1,000,000
+17.6%
13.91%
-4.7%
Q4 2016$37,757,000
+4.7%
850,000
-15.0%
14.60%
-9.6%
Q3 2016$36,050,000
+483.9%
1,000,000
+122.2%
16.16%
+195.2%
Q2 2016$6,174,000450,0005.47%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders